Dimitri Eynikel

I have decided some time ago that I will leave @MSF at the end of this week. This will end an incredible journey from Haiti & Afghanistan to the heart of #EU decision-making. I will now take a long break & take time to find a new exciting endeavor. linkedin.com/feed/update/ur…

Zo komt de gruwel van oorlog wel erg dichtbij natuurlijk. 15.000 dode kinderen is blijkbaar geen enkel probleem, maar een zoon die een bruiloft moet uitstellen: de horror! Want ja, die zaal lag wel al lang op voorhand vast, en die waarborg ben je kwijt, hé.

@JeffBezos David is the respectable party in your story.

I shared this note with the Washington Post team this morning: I’m writing to let you know about a change coming to our opinion pages. We are going to be writing every day in support and defense of two pillars: personal liberties and free markets. We’ll cover other topics too of course, but viewpoints opposing those pillars will be left to be published by others. There was a time when a newspaper, especially one that was a local monopoly, might have seen it as a service to bring to the reader’s doorstep every morning a broad-based opinion section that sought to cover all views. Today, the internet does that job. I am of America and for America, and proud to be so. Our country did not get here by being typical. And a big part of America’s success has been freedom in the economic realm and everywhere else. Freedom is ethical — it minimizes coercion — and practical — it drives creativity, invention, and prosperity. I offered David Shipley, whom I greatly admire, the opportunity to lead this new chapter. I suggested to him that if the answer wasn’t “hell yes,” then it had to be “no.” After careful consideration, David decided to step away. This is a significant shift, it won’t be easy, and it will require 100% commitment — I respect his decision. We’ll be searching for a new Opinion Editor to own this new direction. I’m confident that free markets and personal liberties are right for America. I also believe these viewpoints are underserved in the current market of ideas and news opinion. I’m excited for us together to fill that void. Jeff

Only in the EU is it possible to fast-track a delay

@johnroshanj Between Gmail and outlook account I mean

I need help! I'm trying to add my #Outlook email as an alias in #Gmail, but I keep getting an authentication error. I've double-checked the SMTP server, port, username, and password. Any tips on how to resolve this? Thanks!

@johnroshanj I used to integrate calenders but at some point this was blocked. So not sure if what you want to do is possible.

Ebola-like Marburg virus is spreading and there are no approved vaccines or drugs for the disease. Changing that presents a strange conundrum. No one wants an outbreak of a deadly disease. But those outbreaks mean drugs can be tested. More in Prognosis: bloomberg.com/news/newslette…

"It appears that the @msf Access Campaign, as it has existed for many years, is over." @MSF_access thebody.com/article/msf-ac…

🚨BREAKING: #RightToBreathe campaigners & allies protest outside @VertexPharma HQ in Boston! We have delivered a petition signed by over 142,000 people, demanding that Vertex makes its lifesaving #cysticfibrosis medicine accessible to everyone, everywhere. 🫁🌍

Tomorrow, world leaders meet at the UN High level meeting #UNHLM on antimicrobial resistance to agree on a political declaration committing to respond to #AMR. We urge them to take swift, bold action to translate this declaration into meaningful progress🧵 msfaccess.org/un-political-d…

Diabetes meds like #Ozempic are sold at up to 40,000% markup while patients struggle to access them. They can be sold at profit for $0.89/month, but costs $115 in South Africa & $353 in the US. @MSF_access is demanding @EliLillyandCo @novonordisk @sanofi make them affordable

At the UN High-level Meeting (#UNHLM) on Antimicrobial Resistance (#AMR) on Sep 26, govts will sign a global political declaration committing to respond to AMR. As a medical humanitarian org addressing the challenge of AMR, here are our recommendations for the declaration 🧵👇

European Union: The mpox outbreak signals the importance of concluding a Pandemic Agreement that would effectively respond to the full PPR cycle . #INB11

Why does @DanaherCorp refuse to release the GeneXpert audit they promised to make public? Is it because tests cost less than they claim? Is it because they're just dilly-dallying while 100,000 people die of TB every MONTH? Regardless, it's unacceptable. msfaccess.org/hidden-costs-g…

Sep 2023: @DanaherCorp announces new ‘at cost’ price ($7.97) for @CepheidNews’ GeneXpert #TB test & commits to an annual audit of production costs👍 Now: Still no info on the audit 👎 We, @TAGTeam_Tweets & @PIH urge them to ensure a transparent audit 🧵 msfaccess.org/hidden-costs-g…

An HIV prevention drug that is 100% effective: this is a game-changer! Now to ensure lives over profit. Pleased to see @TheLancet back @UNAIDS' call for @GileadSciences to make lenacapavir available rapidly & affordably to all who need in low- & middle-income countries. thelancet.com/journals/lanhi…

. @WHO urges rapid access to #mpox diagnostic tests, invites manufacturers to emergency review who.int/news/item/29-0…

BREAKING: The Lancet backs UNAIDS call on Gilead to drop the price & share the tech for the new HIV prevention medicine that only needs two injections a year. Their Editorial demands “the price will need to be a lot lower” and warns “the world is watching to see how Gilead acts.”

Sign this petition calling on @GileadSciences to make the #HIV drug #lenacapavir accessible for people in low- & middle-income countries. Right now it's sold in high-income countries for treatment at $42,000/yr! But generics could be made for just $40. ✍️ secure.avaaz.org/campaign/en/en…